The Valley Desk

NCT00423046 · Interventional trial

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Overall registry status Completed

Phase 3

Conditions Infections, Papillomavirus, Papillomavirus Vaccines

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov